The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiencesReview Published on 2022-01-012023-07-11 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] COVID19(2023년), [키워드] clinical trials COVID-19 practical experiences Riamilovir SARS-CoV-2 triazavirin [Article Type] Review